Acadia Pharmaceuticals reported $5.21M in Cost of Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 5.21M 0.51M
Adamas Pharmaceuticals ADMS:US 527K 142K
Alexion Pharmaceuticals ALXN:US $ 125.4M 26.8M
ALKERMES ALKS:US 53.12M 12.1M
Alnylam Pharmaceuticals ALNY:US $ 30.26M 7.23M
Biogen BIIB:US $ 459.7M 18.4M
Biomarin Pharmaceutical BMRN:US $ 127.06M 6.9M
Bristol Myers Squibb BMY:US $ 2451M 52M
Corcept Therapeutics CORT:US $ 1.38M 0.12M
Eisai 4523:JP Y 39250M 1899M
Eli Lilly And LLY:US $ 1953.2M 74.6M
Gw Pharmaceuticals GWPH:US $ 11.81M 1.39M
Intercept Pharmaceuticals ICPT:US $ 0.62M 0.19M
Intra Cellular Therapies ITCI:US $ 2.04M 0.58M
Johnson & Johnson JNJ:US $ 7587M 551M
Moderna Inc MRNA:US 750M 557M
Neurocrine Biosciences NBIX:US $ 3.1M 0.2M
Pfizer PFE:US $ 6992M 2820M
Ptc Therapeutics PTCT:US $ 7.36M 1.75M
Sarepta Therapeutics SRPT:US $ 19.52M 2.83M
Seattle Genetics SGEN:US $ 78.09M 13.96M
Ultragenyx Pharmaceutical RARE:US $ 3.14M 2.05M
Vanda Pharmaceuticals VNDA:US $ 6.57M 0.54M
Vertex Pharmaceuticals VRTX:US $ 227.97M 35.64M
YTE INCY:US $ 32.63M 8.81M
Zogenix ZGNX:US $ 1.22M 0.55M